Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: An Analysis of the Literature on Efficacy, Morbidity, and Mortality

American Journal of Gastroenterology

Volumn 98, Issue 11, 2003, Pages 2521-2527

  Russo, Mark W ^a   Sood, Asheesh ^b   Jacobson, Ira M ^b   Brown Jr , Robert S ^b  

^a IL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; SODIUM;

ARTICLE; ASCITES; BRAIN DISEASE; CHILD; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; HYPERBILIRUBINEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MEDLINE; MORBIDITY; OUTCOMES RESEARCH; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RISK FACTOR; SODIUM EXCRETION; SODIUM URINE LEVEL; STENOSIS; SURGICAL MORTALITY;

EID: 0344927213     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.08664.x     Document Type: Article

References (32)

1. Epstein M. Treatment of refractory ascites. N Engl J Med 1989;321:1675-7.
2. Laberge JM, Somberg KA, Lake JR, et al. Two year outcome following transjugular intrahepatic portosystemic stent-shunt for variceal bleeding: Results in 90 patients. Gastroenterology 1995;108:1143-51.
3. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-7.
4. Salerno F, Merli M, Cazzaniga M, et al. Randomized controlled study of TIPS vs. Paracentesis with albumin in cirrhosis with refractory ascites. Hepatology 2002;36:318A (abstract).
5. Sanyal AJ, Genning C, Reddy KR, et al., and the NASTRA Group. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003;124:634-41.
6. Rees CJ, Rose JD, Record CO, et al. Transjugular intrahepatic portosystemic shunt: A limited role in refractory ascites. Eur J Gastroenterol Hepatol 1997;9:969-73.
7. Williams DB, Waugh R, Selby W. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites. Aust New Zealand J Med 1998;28:620-6.
8. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-7.
9. Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial. J Hepatol 1996;25:135-44.
10. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71.
11. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002;123:1839-47.
12. Le Moine O, Nevens F, Deviere J, et al. TIPS for refractory ascites. A Belgian two center experience. Hepatology 1996; 24(suppl):445A (abstract).
13. Benner KG, Sahagun G, Saxon R, et al. What predicts survival and resolution of refractory ascites after TIPS? Hepatology 1996;24(suppl):449A (abstract).
14. Hills C, Miller LS, Ter H, et al. Increased colloid pressure correlates with resolution of refractory ascites after transjugular intrahepatic portal-systemic shunt (TIPS). Hepatology 1995;22(suppl): 165A (abstract).
15. Peron JM, Rousseau H, Vinel JP, et al. TIPS in the treatment of refractory ascites: Results in 31 consecutive patients with cirrhosis. Gastroenterology 1995;108(suppl):1145A (abstract).
16. Sezai S, Kamisaka K, Hirano M. Effectiveness of transjugular intrahepatic shunt (TIPS) for refractory ascites. Hepatology 1995;22(suppl): 489A (abstract).
17. Thuluvath PJ, Mitchell S, Prescott C, Osterman F. TIPSS for refractory ascites and advanced cirrhosis. Hepatology 1995; 22(suppl):165A (abstract).
18. Shrestha R, McKinley C, Showalter R, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for ascites: The prognostic and predictive value of quantitative liver function tests. Hepatology 1996;24:449A (abstract).
19. Wong F, Sniderman, K, Liu P, et al. Transjugular intrahepatic portosystemic stent shunt: Effects on hemodynamics and sodium hemostasis in cirrhosis and refractory ascites. Ann Intern Med 1995;122:816-22.
20. Ferral H, Bjarnason H, Wegryn SA, et al. Refractory ascites. Early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993;189:795-801.
21. Nazarian GK, Bjarnason, H, Dietz CA Jr, et al. Refractory ascites: Midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997;205:173-80.
22. Forrest EH, Stanley AJ, Redhead DN, et al. Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Ther 1996;10:801-6.
23. Deschenes M, Dufresne MP, Bao B, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999;94:1361-5.
24. Trotter JF, Suhocki PV, Rockey DC. Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: Effect of body weight and Child-Pugh Score. Am J Gastroenterol 1998;93:1891-4.
25. Somberg KA, Lake JR, Tomlanovich SJ, et al. Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function. Hepatology 1995;21:709-16.
26. Crenshaw WB, Gordon FD, McEniff NJ, et al. Severe ascites. Efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996;200:185-92.
27. Martinet JP, Fenyves D, Legault L, et al. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS). Dig Dis Sci 1997;42:161-6.
28. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995;21:709-16.
29. Jalan R, Elton R, Redhead DN, et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal hemorrhage. J Hepatol 1995;23:123-8.
30. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
31. Russo MW, Jacques PF, Mauro M, et al. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt. Liver Transplant 2002;8:271-7.
32. Chalasani N, Clark WS, Martin LG, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118:138-44.